Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 23886048)


The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression.

Buscher A, Mugavero M, Westfall AO, Keruly J, Moore R, Drainoni ML, Sullivan M, Wilson TE, Rodriguez A, Metsch L, Gardner L, Marks G, Malitz F, Giordano TP.

AIDS Patient Care STDS. 2013 Aug;27(8):459-66. doi: 10.1089/apc.2013.0105. Epub 2013 Jul 26.


Risk Prediction Tool for Medical Appointment Attendance Among HIV-Infected Persons with Unsuppressed Viremia.

Woodward B, Person A, Rebeiro P, Kheshti A, Raffanti S, Pettit A.

AIDS Patient Care STDS. 2015 May;29(5):240-7. doi: 10.1089/apc.2014.0334. Epub 2015 Mar 6.


Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy.

Romih V, Zidovec Lepej S, Gedike K, Lukas D, Begovac J.

PLoS One. 2010 Nov 24;5(11):e15051. doi: 10.1371/journal.pone.0015051.


Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

Stürmer M, Dauer B, Moesch M, Haberl A, Mueller A, Locher L, Knecht G, Hanke N, Doerr HW, Staszewski S.

Antivir Ther. 2007;12(1):25-30.


Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.

Joao EC, Gouvêa MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, Ceci L, Cardoso CA, Teixeira Mde L, Calvet GA, Matos HJ.

Int J STD AIDS. 2012 Jan;23(1):44-7. doi: 10.1258/ijsa.2011.010545.


Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release.

Spaulding AC, Messina LC, Kim BI, Chung KW, Lincoln T, Teixeira P, Avery AK, Cunningham M, Stein MS, Ahuja D, Flanigan TP.

AIDS Behav. 2013 Oct;17 Suppl 2:S203-11. doi: 10.1007/s10461-012-0341-8.


Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death.

Colubi MM, Pérez-Elías MJ, Elías L, Pumares M, Muriel A, Zamora AM, Casado JL, Dronda F, López D, Moreno S; SEAD Study Group.

HIV Clin Trials. 2012 Sep-Oct;13(5):289-95. doi: 10.1310/hct1305-289.


[Analysis of variables associated to undetectable viral load and therapeutic failure in HIV-infected individuals].

Eiros JM, Mayo A, Ortega Md Mdel P, Hernández B, Labayru C, Ortiz De Lejarazu R.

Med Clin (Barc). 2002 May 18;118(18):689-93. Spanish.


Long-term lopinavir/ritonavir monotherapy in HIV-infected children.

Kosalaraksa P, Ananworanich J, Puthanakit T, Pinyakorn S, Lumbiganon P, Chuanjaroen T, Chobkarjing U, Phanuphak P, Pancharoen C, Bunupuradah T; HIV-NAT 077 Study Team.

Pediatr Infect Dis J. 2013 Apr;32(4):350-3. doi: 10.1097/INF.0b013e31827b1bd3.


Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.

Germanaud D, Derache A, Traore M, Madec Y, Toure S, Dicko F, Coulibaly H, Traore M, Sylla M, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2010 Jan;65(1):118-24. doi: 10.1093/jac/dkp412. Epub .


Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort.

Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J.

PLoS One. 2012;7(7):e40902. doi: 10.1371/journal.pone.0040902. Epub 2012 Jul 17.


Factors associated with the failure of HIV-positive persons to return for scheduled medical visits.

Arici C, Ripamonti D, Maggiolo F, Rizzi M, Finazzi MG, Pezzotti P, Suter F.

HIV Clin Trials. 2002 Jan-Feb;3(1):52-7.


A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.

Gilks CF, Walker AS, Munderi P, Kityo C, Reid A, Katabira E, Goodall RL, Grosskurth H, Mugyenyi P, Hakim J, Gibb DM; DART Virology Group and Trial Team.

PLoS One. 2013;8(2):e57580. doi: 10.1371/journal.pone.0057580. Epub 2013 Feb 21.


Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Tukei VJ, Murungi M, Asiimwe AR, Migisha D, Maganda A, Bakeera-Kitaka S, Kalyesubula I, Musoke P, Kekitiinwa A.

BMC Pediatr. 2013 Mar 27;13:42. doi: 10.1186/1471-2431-13-42.


Impact and programmatic implications of routine viral load monitoring in Swaziland.

Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Jouquet G, Kerschberger B, Mekeidje C, Cyr J, Mafikudze A, Han W, Lujan J, Teck R, Antierens A, van Griensven J, Reid T.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):45-51. doi: 10.1097/QAI.0000000000000224.


Racial disparities in HIV virologic failure: do missed visits matter?

Mugavero MJ, Lin HY, Allison JJ, Giordano TP, Willig JH, Raper JL, Wray NP, Cole SR, Schumacher JE, Davies S, Saag MS.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):100-8. doi: 10.1097/QAI.0b013e31818d5c37.


Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J.

J Hum Virol. 1999 Nov-Dec;2(6):344-9.


Efficacy of a clinical decision-support system in an HIV practice: a randomized trial.

Robbins GK, Lester W, Johnson KL, Chang Y, Estey G, Surrao D, Zachary K, Lammert SM, Chueh HC, Meigs JB, Freedberg KA.

Ann Intern Med. 2012 Dec 4;157(11):757-66. doi: 10.7326/0003-4819-157-11-201212040-00003.


Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV.

Svedhem-Johansson V, Pugliese P, Brockmeyer NH, Thalme A, Michalik C, Esser S, Barlet MH, Nakonz T, Jimenez-Exposito MJ.

Curr HIV Res. 2013 Jun;11(4):333-41.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk